IO Biotech Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
78
- Latest Deal Type
-
Liquidation
IO Biotech General Information
Description
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Contact Information
Website
www.iobiotech.comCorporate Office
- Ole Maaløes Vej 3
- 2200 Copenhagen
- Denmark
Corporate Office
- Ole Maaløes Vej 3
- 2200 Copenhagen
- Denmark
IO Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Bankruptcy: Liquidation | 01-Apr-2026 | Completed | Bankruptcy: Liquidation | |||
| 9. Merger/Acquisition | 21-Jan-2026 | Cancelled | Generating Revenue | |||
| 8. Debt - General | 23-Dec-2024 | Completed | Generating Revenue | |||
| 7. PIPE | 11-Aug-2023 | Completed | Generating Revenue | |||
| 6. IPO | 05-Nov-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 07-Oct-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 13-Jan-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 22-Jul-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 05-Jan-2016 | $11.9M | $12.5M | Completed | Startup | |
| 1. Early Stage VC (Series B) | 22-Jan-2015 | $595K | $595K | Completed | Startup |
IO Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 164,758 | $63.03 | $63.03 | 1x | $63.03 | 8.99% | ||
| Ordinary Shares | 53,303 | $57.48 | $57.48 | 1x | $57.48 | 2.91% |
IO Biotech Comparisons
Industry
Financing
Details
IO Biotech Competitors (50)
One of IO Biotech’s 50 competitors is ImmunityBio, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ImmunityBio | Formerly VC-backed | San Diego, CA | ||||
| Aura Biosciences | Formerly VC-backed | Boston, MA | ||||
| Hansa Biopharma | Corporation | Lund, Sweden | ||||
| GT Biopharma | Corporation | San Francisco, CA | ||||
| Alaunos Therapeutics | Formerly VC-backed | Fort Lauderdale, FL |
IO Biotech Patents
IO Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023374733-A1 | Tgf-beta-1 vaccine | Pending | 04-Nov-2022 | ||
| EP-4611788-A1 | Tgf-beta-1 vaccine | Pending | 04-Nov-2022 | ||
| US-20260176313-A1 | Tgf-beta-1 vaccine | Pending | 04-Nov-2022 | ||
| WO-2024094850-A1 | Tgf-beta-1 vaccine | Inactive | 04-Nov-2022 | ||
| GB-202216449-D0 | Tgf-beta1 vaccine | Inactive | 04-Nov-2022 | C07K14/495 |
IO Biotech Signals
IO Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
IO Biotech FAQs
-
When was IO Biotech founded?
IO Biotech was founded in 2014.
-
Where is IO Biotech headquartered?
IO Biotech is headquartered in Copenhagen, Denmark.
-
What is the size of IO Biotech?
IO Biotech has 78 total employees.
-
What industry is IO Biotech in?
IO Biotech’s primary industry is Drug Discovery.
-
Is IO Biotech a private or public company?
IO Biotech is a Private company.
-
What is IO Biotech’s current revenue?
The current revenue for IO Biotech is .
-
How much funding has IO Biotech raised over time?
IO Biotech has raised $435M.
-
Who are IO Biotech’s competitors?
ImmunityBio, Aura Biosciences, Hansa Biopharma, GT Biopharma, and Alaunos Therapeutics are some of the 50 competitors of IO Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process